Giesen, A., Devos, G., Tosco, L., Baldewijns, M., Gevaert, T., Goffin, K., Bidakhvidi, N. A., Laenen, A., Raskin, Y., Haute, C. V., Goeman, L., Meerleer, G. D., Berghen, C., Devlies, W., Claessens, F., Poppel, H. V., Everaerts, W., Joniau, S. (2025). Final oncological outcomes of the randomized phase II trial ARNEO: Neoadjuvant degarelix with or without apalutamide prior to radical prostatectomy for high-risk prostate cancer.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.5_suppl.394